Shamburg News · 8-K filed Oct 7, 2026, 9:00 AM EDT

BioCardia Presents CardiAMP HF II Trial Design at Heart Failure Society of America Meeting

BCDA · BioCardia, Inc.

  • Other event
  • Materiality: low

On October 7, 2026, BioCardia, Inc. issued a press release announcing a scientific poster presentation on the design of its CardiAMP HF II trial at the Heart Failure Society of America Annual Scientific Meeting in Phoenix, AZ, scheduled for October 9 to 12, 2026. The filing states that FDA has agreed the ongoing CardiAMP HF II trial may be sufficient to support FDA approval. The information was furnished under Item 8.01 and Exhibit 99.1 and is not deemed filed.

Read the filing on EDGAR ↗

Source: SEC EDGAR, Form 8-K, Items 8.01, 9.01, accession 0001437749-26-032270.

Written from the filing by Shamburg Markets. Figures are as reported by the company.